Japanease multi-center clinical trial to assess the inhibitory effects of branched chain amino acids on the recurrence after curative treatment of hepatocellular carcinoma

INTERVENTION: Diet therapy group Diet + BCAA therapy group CONDITION: Hepatocellular carcinoma PRIMARY OUTCOME: Time to recurrence of hepatocellular carcinoma SECONDARY OUTCOME: Survival time, ; Change of hepatic reserve, ; Change of lipid metabolisum and glucose tolerance, ; Change of nutritional state, etc INCLUSION CRITERIA: The following HCC patients who are curatively treated with resection or RFA. 1.20 years of age and older. 2.HCV RNA positive liver cirrhosis and 2.8‐4.0 g/dl in serum albumin level. 3.New‐onset HCC (no extrahepatic lesion, no more than 3lesions and the largest measuring 3cm and below). 4.Clinical diagnosis with imaging tests and tumor markers, add to pathological findings in impossible cases. 5.Comfirmation of no recurrence with CE‐CT or CE‐US, MRI at a month after treatment.